DE69821019D1 - 3-carboalkoxy-2,3-dihydro-1h-phenothiazin-4(10h)-one derivate - Google Patents

3-carboalkoxy-2,3-dihydro-1h-phenothiazin-4(10h)-one derivate

Info

Publication number
DE69821019D1
DE69821019D1 DE69821019T DE69821019T DE69821019D1 DE 69821019 D1 DE69821019 D1 DE 69821019D1 DE 69821019 T DE69821019 T DE 69821019T DE 69821019 T DE69821019 T DE 69821019T DE 69821019 D1 DE69821019 D1 DE 69821019D1
Authority
DE
Germany
Prior art keywords
phenothiazin
carboalkoxy
derivate
dihydro
coor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69821019T
Other languages
English (en)
Other versions
DE69821019T2 (de
Inventor
R Scott
L Laws
R Roberts
M Nicholson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Howard University
Original Assignee
Howard University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Howard University filed Critical Howard University
Publication of DE69821019D1 publication Critical patent/DE69821019D1/de
Application granted granted Critical
Publication of DE69821019T2 publication Critical patent/DE69821019T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D279/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms
    • C07D279/10—1,4-Thiazines; Hydrogenated 1,4-thiazines
    • C07D279/14—1,4-Thiazines; Hydrogenated 1,4-thiazines condensed with carbocyclic rings or ring systems
    • C07D279/18—[b, e]-condensed with two six-membered rings
    • C07D279/20—[b, e]-condensed with two six-membered rings with hydrogen atoms directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/12—Antiepileptics; Anticonvulsants for grand-mal

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pain & Pain Management (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
DE69821019T 1997-10-27 1998-10-27 3-carboalkoxy-2,3-dihydro-1h-phenothiazin-4(10h)-one derivate Expired - Fee Related DE69821019T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US958320 1978-11-06
US08/958,320 US5994349A (en) 1997-10-27 1997-10-27 3-carboalkoxy-2, 3-dihydro-1H-phenothiazin-4[10H]-one derivatives
PCT/US1998/022693 WO1999021560A1 (en) 1997-10-27 1998-10-27 3-carboalkoxy-2,3-dihydro-1h-phenothiazin-4[10h]-one derivatives

Publications (2)

Publication Number Publication Date
DE69821019D1 true DE69821019D1 (en) 2004-02-12
DE69821019T2 DE69821019T2 (de) 2004-10-28

Family

ID=25500854

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69821019T Expired - Fee Related DE69821019T2 (de) 1997-10-27 1998-10-27 3-carboalkoxy-2,3-dihydro-1h-phenothiazin-4(10h)-one derivate

Country Status (11)

Country Link
US (1) US5994349A (de)
EP (1) EP1027055B1 (de)
AT (1) ATE257382T1 (de)
AU (1) AU748596B2 (de)
CA (1) CA2308281C (de)
DE (1) DE69821019T2 (de)
DK (1) DK1027055T3 (de)
ES (1) ES2212370T3 (de)
IL (1) IL135842A (de)
PT (1) PT1027055E (de)
WO (1) WO1999021560A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW201536795A (zh) * 2013-05-31 2015-10-01 Medeia Therapeutics Ltd 作為細胞保護劑用之芳基噻嗪化合物
CN106117247B (zh) * 2016-06-29 2018-02-16 东华大学 一种2‑甲基‑1,2,3,9‑四氢苯并[b]吡咯[1,4]‑噻嗪‑1,3‑二酮类化合物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3229122A1 (de) * 1982-08-04 1984-02-09 Bayer Ag, 5090 Leverkusen Anellierte 4h-1,4-benzothiazine, verfahren zu ihrer herstellung und ihre verwendung als arzneimittel
DE3426564A1 (de) * 1984-07-19 1986-01-30 Bayer Ag, 5090 Leverkusen Verwendung von 4h-1,4-benzothiazinen bei der prophylaxe und therapie von erkrankungen der atemwege, entzuendungen/rheuma, thromboembolischen erkrankungen, ischaemien und infarkten, herzrhythmusstoerungen, arteriosklerose und dermatosen, arzneimittel zu diesem zweck sowie wirkstoffe, die in diesen arzneimitteln enthalten sind
US5580894A (en) * 1996-01-11 1996-12-03 Howard University Isoxazolyl enaminones

Also Published As

Publication number Publication date
EP1027055B1 (de) 2004-01-07
CA2308281C (en) 2004-08-24
AU748596B2 (en) 2002-06-06
IL135842A (en) 2004-06-01
US5994349A (en) 1999-11-30
DK1027055T3 (da) 2004-04-26
EP1027055A1 (de) 2000-08-16
CA2308281A1 (en) 1999-05-06
IL135842A0 (en) 2001-05-20
WO1999021560A1 (en) 1999-05-06
EP1027055A4 (de) 2001-12-05
ES2212370T3 (es) 2004-07-16
DE69821019T2 (de) 2004-10-28
PT1027055E (pt) 2004-05-31
ATE257382T1 (de) 2004-01-15
AU1201399A (en) 1999-05-17

Similar Documents

Publication Publication Date Title
IL131172A (en) 1-phenyl-4-benzylpiperazines: dopamine receptor subtype specific ligands (d4)
IE790064L (en) Tetrahydropyridinylindoles
TR199902897T2 (xx) S�v� benz-izo-kuinolin t�revleri.
TW427982B (en) Polysubstituted 3-acylamino-5-phenyl-1,4-benzodiazepin-2-one derivatives, process for their preparation and the pharmaceutical compositions containing them
MY123083A (en) Acyclic nucleoside derivatives
GR3032198T3 (en) Androstenones
EP0776204A4 (de) Indolalkaloide als uv-schutz und als antientzündliche wirkstoffe
IL69882A0 (en) Analgesia-effecting 5-hydroxytryptophan derivatives
IE861633L (en) Carboxamide indole derivatives
DE69821019D1 (en) 3-carboalkoxy-2,3-dihydro-1h-phenothiazin-4(10h)-one derivate
HUP0004317A2 (hu) 5-HT1F agonisták
IE812498L (en) Pyrimidine derivatives.
AU539870B2 (en) 2-phenylamino-imidazolines-(2)
AU584988B2 (en) New 8-thiotetrahydroquinoline derivatives and salts thereof
ES8504181A1 (es) Procedimiento para preparar nuevos derivados de piperidina
YU200791A (sh) Trifluorometil 1-karba (1-detia) cefemi
AU551901B2 (en) Substituted thienobenzodiazepinones
AU535927B2 (en) 2-phenylamino-imidazolines
JPS56154431A (en) Substituted 3-aryl-2-cycloalkene-1-one and its manufacture
CO4920233A1 (es) Acidos aminobutiricos gamma substituidos como agentes farmaceuticos
DE3660546D1 (en) Phosphoroimidates
IE832550L (en) Semicarbazides.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee